Search results
27-year-old battling rare cancer uses social media to help break stigmas
Good Morning America via Yahoo News· 4 days agoNatasha Allen looks at the world through heart shaped lenses -- quite literally. Complementing the...
Our Queerest Century: A curated timeline
LA Times via Yahoo News· 15 hours agoRegistered nurse Bobbi Campbell takes pictures of his Kaposi sarcoma lesions and posts them in the heart of San Francisco's Castro District. 1982: The...
Aspiring teenage photographer battling cancer is working her way through her bucket list
Digital Camera World via Yahoo News· 1 day agoOnly 12 cases of desmoplastic small round cell tumor are diagnosed each year in England, according...
Our Queerest Century: A curated timeline
Los Angeles Times· 15 hours agoWith queer lives and culture under threat, Our Queerest Century highlights the contributions of LGBTQ+ people since the 1924 founding of the nation’s...
Experimental therapy shows promise in pancreatic cancer clinical trial
Medical Xpress· 6 days agoIt acts by inflaming the microenvironment surrounding the tumor and thereby augmenting the activity...
Carolina hospitals team up to find solutions for pediatric cancer
WSOC-TV Charlotte· 1 day agoDoctors estimate that every year in the Carolinas, about 700 children are diagnosed with cancer. A...
To fight cancer misinformation, we need better health literacy
Chicago Sun-Times· 3 days agoAn oncologist recently shared a story with us about a patient with a rare but often curable form of...
Cryoablation: Purpose and what to expect
Medical News Today· 24 hours agoCryoablation involves applying extremely cold gas or liquid to an area of cancerous or abnormal tissue. The treatment freezes and destroys the cells....
He Was 47 When They Met. She Was 17. Their Life Together Was Beautiful, But …
Slate· 1 day agoJill Ciment met her husband of 45 years, the painter Arnold Mesches, when he was her art teacher....
A Deeper Look at Anti-PD-1/PD-L1 Checkpoint Inhibitors for Cancer
Forbes· 7 days agoIn a previous story, I described pembrolizumab, a PD-1 targeting checkpoint inhibitor, in some...